Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;25(3):e14004.
doi: 10.1111/petr.14004. Epub 2021 Mar 17.

Haploidentical hematopoietic cell transplantation is even more advantageous during the COVID-19 pandemic

Kelly Stanley  1   2 , Santosh Hanmod  1   3 , Richard J Simpson  1   4   5   6 , Emmanuel Katsanis  1   2   3   5   6   7   8
Affiliations
Comment

Haploidentical hematopoietic cell transplantation is even more advantageous during the COVID-19 pandemic

Kelly Stanley et al. Pediatr Transplant. 2021 May.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Time course of SARS‐CoV‐2 viral monitoring of donor and recipient and disease course
See this image and copyright information in PMC

Comment on

References

    1. Ljungman P, Mikulska M, de la Camara R, et al. The challenge of COVID‐19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T‐cell therapy. Bone Marrow Transplant. 2020;55(11):2071‐2076. 10.1038/s41409-020-0919-0. - DOI - PMC - PubMed
    1. Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID‐19 in haematopoietic stem‐cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8(3):e185‐e193. 10.1016/S2352-3026(20)30429-4 - DOI - PMC - PubMed
    1. Zeng Y, Katsanis E. Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation. Bone Marrow Transplant. 2017;52(12):1671‐1673. 10.1038/bmt.2017.186. - DOI - PubMed
    1. Katsanis E, Sapp LN, Reid SC, Reddivalla N, Stea B. T‐Cell replete myeloablative haploidentical bone marrow transplantation is an effective option for pediatric and young adult patients with high‐risk hematologic malignancies. Front Pediatr. 2020;8:282. 10.3389/fped.2020.00282. - DOI - PMC - PubMed
    1. Katsanis E, Sapp LN, Varner N, Koza S, Stea B, Zeng Y. Haploidentical bone marrow transplantation with post‐transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies. Biology Blood Marrow Transplant. 2018;24(10):2034‐2039. 10.1016/j.bbmt.2018.06.007. - DOI - PMC - PubMed